governmentofindia Archives - Page 2 of 2 - Medically Speaking
Home Tags Posts tagged with "governmentofindia"
Tag:

governmentofindia

Uncategorized

Maha Covid Spike: 1121 cases in last 24 hrs

by Medically Speaking Team
written by Medically Speaking Team
  • odisha covid 19 1585929659

Where on one hand, the largest vaccine drive crossed 1 crore mark, the number of Covid-19 cases in Maharashtra is uncontrollably spiking on the other. A total of 1121 cases came out in the last 24 hours in Mumbai with 6 casualties.

The report is based on the information received from various hospitals and data uploaded by certified labs on GOI ICMR portal/ Covid Portal. In a report by the Municipal Corporation of Greater Mumbai, it was revealed that the total number of patients recovered and discharged in these 24 hours was 734.

For more updates on Covid-19, stay tuned to www.medicallyspeaking.in

0 comment
0 FacebookTwitterPinterestEmail
Uncategorized

Dr Harsh Vardhan releases WHO’s World Report on Hearing

by Medically Speaking Team
written by Medically Speaking Team

On the occasion of World hearing day the Union Health Minister Dr.Harsh Vardhan released WHO report that observed 2 % of India’s population , maily children, suffered fom the condition of Otitis Media.

“So prevalent is the condition that some people even consider it natural for a child’s ears to discharge.”

Dr. Harsh Vardhan also observed and highlighted other hearing loss related problems due to high noise levels at workplaces, on the roads, hearing loss due to the use of ototoxic medicines and chemicals, the dangers of loud music and unsafe listening to people’s hearing health (with over 750 million smart phone users in India).

He also informed audience about the study, “A multi – centric cross-sectional survey conducted as per the WHO recommended Probability Proportional to Size (PPS) sampling technique assessed 92,097 people in the community across 6 sites in India. Age-appropriate audiological testing as per WHO norms including pure tone audiometry, tympanometry, oto-acoustic emissions, behavioral observation audiometry and ENT examination were all undertaken onsite in a specially designed sound treated audiological bus.” The sample size makes this the world’s largest such study to-date.           

“The results have showed a changing profile of hearing loss in India’s population and in tune with similar changes in other countries as they move forward in economic development. The study showed that the disabling hearing loss affected 2.9% of the population and was noted to effect communication, education and work. The rural population had a far greater prevalence of hearing loss. The prevalence of total hearing loss, unilateral &bilateral was found to be as high as 9.93%. The geriatric population accounted for 40.5% of all hearing loss and 72.4% of all disabling hearing loss. The study also made a major contribution in identifying the risk factors associated with Sensory Neural Hearing Loss (SNHL): Smokeless Tobacco consumption, Heavy smoking, Leisure and work-related noise, and also excessive Residential Noise, are all noted as risk factors associated with SNHL.” states the release 

Dr. Harsh Vardhan also informed the audience that with the COVID pandemic abating in India, the government plans to further strengthen our work on ear and hearing care based on the recommendations of the report:

  • By improving services at community and primary levels through training of health workers for task sharing, in line with the strategies outlined in the report.
  • Expanding access to affordable hearing technologies for all those in need.
  • Using the power of Information Technology (IT) to raise awareness among our youth on safe listening as a means of hearing loss prevention.
0 comment
0 FacebookTwitterPinterestEmail
Uncategorized

No fatalities occurred due to Jab: Health Minister

by Medically Speaking Team
written by Medically Speaking Team

dr harsh

Earlier today after the beginning of second phase of vaccination drive, Union Health Minister said that if a person dies 4-10 days of vaccination, the death can’t be link to inoculation of the Jab since every death has been scientifically investigated and no death has occurred due to vaccine.

He further added that the vaccine has minimal side effects like swelling or fever which happens during a normal vaccine too and that the chance of hospitalization due to vaccination is – 0.0004, it’s negligible.

Today the drive began with giving jabs to the persons aged 60 or above and people aged 45-59 with co-morbidities.

Appointments can be booked through the Co-Win 2.0 portal. A mobile number cannot be used for making more than four registrations, they had said.

Union Health Minister Dr. Harsh Vardhan thanked PM Modi saying that he proved that both the vaccines are safe and perfect as far as immunogenicity is concerned.

”He took COVAXIN, against which a lot of misinformation was spread even when it was scientifically perfect. I think PM has given a clear message to the country. All misinformation & hesitancy should be buried once and for all,” he said.

He said that he will do the booking and will get vaccinated tomorrow, i.e. Tuesday.

0 comment
0 FacebookTwitterPinterestEmail
Uncategorized

Jab registration details released by the government

by Medically Speaking Team
written by Medically Speaking Team
vax thumb l

After having administered 1.5 crore people with the Covid-19 vaccine, second phase of the vaccine drive began today aiming to cover 10 crore people in India. Health ministry said that for the next two days, training will be provided to the health workers and other staff who will administer the vaccine and other standard procedures in the centers.

States and Union Territories have been instructed to keep a scale-up plan ready which includes the granular weekly and fortnightly plans for administering the vaccination sites within the government as well as private facilities along with the number of doses administered.

The following criterion has been set for the administration of Covid-19 vaccination:

Eligibility

People who are above the age of 60 and people within the age of bracket of 45 to 59 years with specified co-morbidities are allowed to take vaccine shots. The government has listed 20 co-morbidities that are covered for vaccination.

  1. Heart failure with hospital admission in past one year.
  2. Post-cardiac transplant/Left-ventricular Assist device (LVAD).
  3. Significant Left-Ventricular Systolic Dysfunction (LVEF<40%).
  4. Moderate or Severe Valvular Heart Disease.
  5. Congenital heart disease with severe PAH or Idiopathic PAH.
  6. Coronary Artery Disease with past CABG/PTCA/MI and Hypertension/Diabetes on treatment.
  7. Angina and Hypertension/Diabetes treatment.
  8. CT/MRI documented stroke and Hypertension/Diabetes on treatment.
  9. Pulmonary artery hypertension and Hypertension/Diabetes on treatment.
  10. Diabetes (>10 years or with complication) and hypertension on treatment.
  11. Kidney/Liver/Hematopoietic stem cell transplant: Recipient/ On wait-list.
  12. End stage kidney disease on haemodialysis/ CAPD.
  13. Current prolonged use of oral corticosteroids/ immunosuppressant medications.
  14. Decompensated cirrhosis.
  15. Severe respiratory disease with hospitalizations in last two years/ FEVI 50%.
  16. Lymphoma/ Leukaemia/ Myeloma.
  17. Diagnosis of any solid cancer on or after July 1, 2020 or currently on any cancer therapy.
  18. Sickle Cell Disease/ Bone Marrow Failure/ Aplastic Anemia/ Thalassemia Major.
  19. Primary Immunodeficiency disease/ HIV infection.
  20. Persons with disabilities due to intellectual disabilities/ Muscular Dystrophy/ Acid attack with involvement of respiratory system / Persons with disabilities having high support needs/ Multiple disabilities including deaf-blindness.

Registration

People who want to get vaccinated in the second phase of Covid-19 vaccination have to register on the Co-Win platform.

Registration on Co-Win 2.0 portal – www.cowin.gov.in – opened at 9 a.m. today.

The beneficiaries can self-register in advance by downloading the Co-Win 2.0 portal and through other IT Applications such as Arogya Setu etc.

For people who are unable to register themselves can directly visit the vaccination center along with the required documents and get themselves registered.

Documents

A government ID proof will be sufficient for people over the age of 60. People aged 45 will have to upload a medical certificate mentioning their comorbid conditions.

The certificate can either be uploaded on Co-win 2.0 by the beneficiary while self-registering or a hard copy can be carried by the beneficiary to the CVC.

Cost of vaccination

The vaccine is free at government hospitals and paid at private hospitals with a cost of 250 per dose (price set by the government).

Where to get vaccinated

The health ministry has released two lists of private hospitals empaneled.

The list can be accessed here:

https://www.mohfw.gov.in/pdf/PMJAYPRIVATEHOSPITALSCONSOLIDATED.xlsx

0 comment
0 FacebookTwitterPinterestEmail
Uncategorized

Breaking – High level meeting chaired by Top officials on Vaccine Administration

by Medically Speaking Team
written by Medically Speaking Team

According to the information given by Government of India, “Union Health Secy, Chairman of Empowered Group on Vaccine Administration (Co-WIN) & member, National Expert Group on Vaccine Administration of COVID chaired a high-level meeting today with Health Secretaries & MDs of States/UTs on vaccination of age-appropriate groups today.” reports ANI

“Advance Self Registration, On-Site Registration & Facilitated Cohort Registration of potential beneficiaries explained to States &UTs. Beneficiaries to be captured on CoWIN2.0 platform, issued QR Code based provisional (on receiving the first does)&final certificates.” Said Government of India

0 comment
0 FacebookTwitterPinterestEmail
Uncategorized

Glenmark receives ‘India Pharma Innovation of the Year’ Award

by Medically Speaking Team
written by Medically Speaking Team
glenmark

Glenmark Pharmaceuticals received the “Indian Pharma Innovation of the Year” Award from the Government of India, as the part of the Indian Pharma & India Medical Device Awards 2021, it announced in a press release.

The 6th edition of the annual awards is jointly organized by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, The Federation of Indian Chambers of Commerce & Industry (FICCI) and Invest India.

The award acknowledges Glenmark’s patents and innovations over the last three years, in its core therapy areas of Dermatology, Respiratory and Oncology. It also recognizes the company’s contribution to the healthcare sector, in meeting both pressing and long-term patients needs.

Commenting on the award win, Mr. Glenn Saldanha, Chairman and Managing Director of Glenmark Pharmaceuticals, said, “Now more than ever, we see the need for continuous innovation in pharma and healthcare to address infectious and chronic diseases. Our goal at all times is to be future-ready, and to this end, innovation is ingrained in all our efforts. We thank the government for its recognition; it serves as an encouraging reminder to keep up our good work in India and the world.”

Glenmark earlier won awards from the Department of Pharmaceuticals under the categories of Indian Pharma Leader Award (2015), Company of the Year (2016), and Corporate Social Responsibility Program of the Year (2017).

About Glenmark:

Glenmark Pharmaceuticals Ltd. (GPL) is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries. For more information, visit www.glenmarkpharma.com .

0 comment
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts
What Happens When You Lack Vitamin A In Your Body? 5 Signs to Watch Out For Why Breast Cancer Screening at 40 is a Life-Saving Choice Avoid These Food and Medicine Combos Identifying Rheumatoid Arthritis: Early Signs and Symptoms to Watch For “Delicious Diabetes-Friendly Smoothies: 5 Homemade Recipes to Satisfy Your Sweet Tooth Without Spiking Blood Sugar”